A Comprehensive Board Review in Hematology and Medical ...

1 A ComprehensiveBoard Review inHematology and Medical OncologySeptember 19-24, 2016 Robert C. Hickey Auditorium Floor 11, R. Lee Clark Clinic, 1515 Holcombe Boulevard The University of Texas MD anderson cancer center Houston, Texas September 19-23, 2016 Solid Tumors and Malignant Hematology September 22-24, 2016 Malignant and Benign Hematology GoalThe course is a 6-day Comprehensive Review of current standards and practices in the management of patients with blood disorders and malignancy. The course is designed to enable the participant to effectively prepare for the American Board of Internal Medicine certification and recertification examinations in Hematology and Medical Oncology.

2 Advances in clinical pharmacology, molecular genetics and risk assessment, and radiation oncology will be ObjectivesAt the conclusion of this educational activity, participants should be able to Apply knowledge gained to prepare for the Hematology and Medical oncology subspecialty and recertification examinations in Hematology and Medical oncology (Knowledge, Competence); Utilize current standards of care for patients with cancer , blood disorders and malignancies (Knowledge, Competence, Performance); Demonstrate proficiency of knowledge in Hematology and Medical oncology (Knowledge, Competence, Performance); Incorporate recent advances in management of hematologic and oncologic patients (Knowledge, Competence, Performance); and Define molecular determinants of cancer risk and apply this knowledge in practice (Knowledge, Competence, Performance).

3 Target AudienceThis program should be of interest to physicians, APNs, physician assistants and Methods Lectures Case-based Question-and-Answer Sessions (in Board examination format) Syllabi (hard copy) A/V USB flash drive recording of conference proceeding. The A/V USB flash drive recording of conference proceedings will be mailed to all registered conference participants approximately 2 weeks after the conference. Sakai an online course management systemA ComprehensiveBoard Review inHematology and Medical OncologyEvaluationA course evaluation form will provide participants with the opportunity to Review each session and speaker, to identify future educational needs, and to comment on any perceived commercial bias in the Designation This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME)

4 Through the joint providership of The University of Texas MD anderson cancer center and Baylor College of Medicine. The University of Texas MD anderson cancer center is accredited by the ACCME to provide continuing Medical education for University of Texas MD anderson cancer center designates this live activity for a maximum of AMA PRA Category 1 Credits . Physicians should claim only the credit commensurate with the extent of their participation in the activity. CME Certificates and Attendance Verification Certificates Certificates awarding AMA PRA Category 1 Credit or certificates documenting attendance will be distributed to participants when an individual departs the conference.

5 To obtain a CME certificate, physicians must submit a completed evaluation questionnaire and a CME Verification Form. Upon request, a record of attendance (certificate) will be provided on-site to other health care professionals for requesting credits in accordance with state nursing boards, specialty societies, or other professional Committee MD anderson cancer center Bonnie Glisson, MD, FACP, Co-Chair Jorge Cortes, MD, Co-Chair Shreyaskumar Patel, MD Sharon Giordano, MD, MPH Tapan Kadia, MDWilliam N. William, Jr., MD Felisha Estelle Baylor College of Medicine Martha Mims, MD, PhD, Co-Chair Gerald Cyprus, MD AGENDAM onday, September 19, 20167:00 am Registration & Continental Breakfast7:45 Welcome and Introduction Bonnie Glisson, MD Jorge Cortes, MD Martha Mims, MDSOLID TUMORS SESSIONB reast Cancer8:00 Screening/Local Management of Breast cancer Jennifer Litton, MD8:45 Systemic Treatment of Primary Breast cancer Including HER2 Positive Breast Disease Clifford Hudis, MD9:45 Break10.

6 00 Treatment of Metastatic Breast cancer Including HER2 Positive Breast Disease Lisa Carey, MD11:00 Special Issues in Breast cancer Sharon Giordano, MD, MPH11:30 Lunch (provided) Solid Tumors Q & A Session 1: Breast/GU/Thyroid (11:45 am 12:35 pm) Mark Lewis, MDGenitourinary Oncology/Thyroid12:45 pm Prostate cancer Celestia Higano, MD, FACP1:30 Urothelial Tumors Walter Stadler, MD2:15 Testicular cancer Timothy Gilligan, MD3:00 Break3:15 Renal Cell Carcinoma Eric Jonasch, MD4:00 Thyroid cancer Marcia Brose, MD, PhD 4:30 AdjournTuesday, September 20, 20167:00 am Registration & Continental BreakfastGastrointestinal Oncology 8:00 Colorectal cancer : Biology and Adjuvant Therapy Axel Grothey, MD8:30 Management of Metastatic Colorectal and Anal cancer Axel Grothey, MD9:30 Break9:45 Esophagus/Gastric cancer /Hepatocellular cancer Harry Yoon, MD 10.

7 45 Pancreatic/Pancreaticobiliary Cancers/ Unknown Primary Gauri Varadhachary, MD12:00 pm Lunch (provided) Solid Tumors Q & A Session 2: GI/GYN/Melanoma/Neuro-Oncology (12:15 pm 1:05 pm) Ravin Ratan, MD Gynecologic Oncology/Melanoma/ Neuro-Oncology 1:15 Ovarian cancer and Unusual Ovarian Histologies James Tate Thigpen, MD2:15 Uterine cancer James Tate Thigpen, MD2:45 Cervical cancer Michael Frumovitz, MD, MPH3:30 Break3:45 Melanoma Michael A.

8 Davies, MD, PhD 4:30 Neuro-Oncology John de Groot, MD5:15 AdjournWednesday, September 21, 20167:00 am Registration & Continental BreakfastLung cancer /Head and Neck/Sarcoma8:00 Management of Stage I-III Non-Small Cell Lung cancer Nasser Hanna, MD8:45 Metastatic Non-Small Cell Lung cancer Nasser Hanna, MD 9:30 Small Cell Lung cancer Bonnie Glisson, MD 10:15 Break10:30 Head and Neck cancer William N. William, Jr., MD, PhD11:15 Sarcoma Shreyaskumar Patel, MD12:15 pm Lunch (provided) ASH/ASCO Choosing Wisely Recommendations (12:30 pm 1:20 pm) Ravin Garg, MDPharmacology/Genetics/Head and Neck1:30 Charles A.

9 Koller, MD Lectureship Award 2016 Recipient: Edward Chu, MD1:35 Pharmacology I Edward Chu, MD2:15 Pharmacology II Edward Chu, MD3:00 Break3:15 Pharmacology III Edward Chu, MD4:00 Genetic Risk Factors Claudine Isaacs, MD4:45 Solid Tumors Q & A - Session 3: Lung/H&N/Sarcoma/Pharm/Genetics Ravin Garg, MD5:35 AdjournThursday, September 22, 20167:00 am Registration & Continental BreakfastMALIGNANT Hematology SESSIONL eukemia 8:00 Chronic Lymphocytic Leukemia and Hairy Cell Leukemia Susan O Brien, MD8:45 Myleoproliferative Neoplasms Ayalew Tefferi, MD9:45 Chronic Myeloid Leukemia Jorge Cortes, MD10:30 Break10:45 Acute Lymphocytic Leukemia Elias Jabbour, MD11:30 Acute Myeloid Leukemia Farhad Ravandi-Kashani, MD12:15 pm Lunch (provided) Free TimeTransplant/Infectious Disease/Lymphoma 1:15 Indications for Stem Cell Transplant Matt Kalaycio, MD2.

10 15 Stem Cell Transplant Supportive Care Uday Popat, MD3:15 Break3:30 Infectious Complications in cancer Patients Javier Adachi, MD4:15 Classification of Lymphoma Lynne Abruzzo, MD, PhD5:00 AdjournFriday, September 23, 20167:00 am Registration & Continental BreakfastMDS/Lymphoma/Myeloma8:00 Myelodysplastic Syndrome Alan List, MD8:45 Aggressive Non-Hodgkin Lymphoma Joseph Connors, MD, FRCPC9:30 Hodgkin Lymphoma Joseph Connors, MD, FRCPC10:15 Break10:30 Indolent Non-Hodgkin Lymphoma Jonathan Friedberg, MD, MMSc11:15 Multiple Myeloma and Other Plasma Cell Dyscrasias Sagar Lonial, MD, FACP12:15 pm Lunch (provided)